Novo Nordisk announced plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, North Carolina, and grow i...

The Ontario government is investing $40 million from the Venture Ontario Fund, dedicated to helping Ontario life sciences companies and biomanufacture...

Simtra BioPharma Solutions, a premier injectable contract development and manufacturing organization (CDMO), recently broke ground on a $250+ million ...

EmpiRx Health, the leading clinically-driven PBM company, announced the opening of a major new office in Orlando, FL. The new office supports EmpiRx H...

The Puerto Rico Industrial Development Company (PRIDCO), under the Department of Economic Development and Commerce (DDEC), recently closed a $52 milli...

QPS, a leading global contract research organization (CRO), continues to expand and align its full-service preclinical, bioanalysis, and clinical capa...

Incyte, a Delaware-founded global biopharmaceutical company with a robust portfolio of treatments across oncology and inflammation and autoimmunity, h...

PharmaLogic Holdings Corp., a world-class contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, announced t...

AdventHealth Daytona Beach announced a multi-year, $220 million construction plan to add 104 beds, four new surgical suites and more than 240,000 squa...